<< BCBSA supports Obama on maintaining health insurance reforms for affordable coverage | Sleep improves memory >>

Read in | English | Deutsch | Norsk

Reportlinker's report analyzes the global market for cancer therapies

Published on September 11, 2009 at 3:15 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue.

World Cancer Therapies Market

http://www.reportlinker.com/p0109886/World-Cancer-Therapies-Market.html

This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forecasts for the global market is provided for the period of 2006 through 2015. A six-year historic analysis is also provided.

The report profiles 207 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Amgen, Inc., AstraZeneca PLC, Bayer Schering Pharma, Biogen Idec Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cell Therapeutics, Inc., Cephalon, Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Genzyme, GlaxoSmithKline, Imclone Systems, Inc., Merck KGaA, Novartis AG, Ortho Biotech Products, L.P, OSI Pharmaceuticals, Inc., Pfizer, Sanofi-Aventis, Schering Plough Corporation, Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited, and Wyeth.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Source: http://www.reportlinker.com

c71c588a-cae4-4601-9b01-62a0dba6211f|0|.0

Posted in: Medical Condition News

Tags: Abraxane, Antibody, Avastin, Biotechnology, Bladder Cancer, Bone, Bone Marrow, Brain, Brain Cancer, Breast Cancer, Cancer, Cell, Cervical Cancer, Chemotherapy, Colorectal Cancer, Diabetes, Diet, Drug Delivery, Gemzar, Gene Therapy, Genetics, Hodgkin's Lymphoma, Hormonal Therapy, Hospital, Immunization, Immunotherapy, Investment, Kidney Cancer, Leukemia, Liposome, Liver Cancer, Lung Cancer, Lymphoma, Medicare, Monoclonal Antibody, Multiple Myeloma, Neutropenia, Non-Hodgkin's Lymphoma, Nutrition, Oncology, Paclitaxel, Pancreatic Cancer, Pfizer, Prostate Cancer, Radiation Therapy, siRNA, Skin Cancer, Smoking, Stem Cell, Tarceva, Temsirolimus, Tobacco, Vaccine, Vectibix, Xeloda

Related posts

Exelixis reports preliminary data from cabozantinib phase 1b trial on RCCExelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with met...
Roche NimbleGen, BGI develop Major Histocompatibility Complex region capture technologyRoche NimbleGen, Inc. and BGI, the world's largest genomic organization, announced that they have de...
Insight into role of cytokines in autoimmune diseasesCytokines, a varied group of signaling chemicals in the body, have been described as the software th...
TriLogic, Mission Pharmacal partner to develop new drug delivery systemMission Pharmacal Company announced today that it is developing a new drug delivery system utilizing...
Smoking cessation improves overall personality: StudyUniversity of Missouri researchers have found evidence that shows those who quit smoking show improv...
FDA to review bone drugs; CDC reports parasite may be a risk to blood supplyTwo advisory panels of the Food and Drug Administration will consider on Friday whether to recommend...
Tips for preventing allergy during ragweed pollen seasonFeel like there's no end in sight when it comes to fall allergy misery? Blame global warming. Resear...
CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society meetingCambridge Heart, Inc. a developer of non-invasive diagnostic tests for cardiac disease, today announ...
Research solves challenging problem of industry-scale production of large RNA moleculesNanotechnology researchers have known for years that RNA, the cousin of DNA, is a promising tool for...
Astellas to acquire all Maxygen's equity interests in Perseid for $76.0 millionMaxygen, Inc. today announced that Astellas Pharma Inc. has exercised its option to purchase all of ...
MD Solarsciences launches new sunscreen lotion at 2011 AAD meetingA year after its launch, the first dermatologist-driven company dedicated to primary skin cancer pro...
Temporary budget compromise would not defund health lawNews outlets covered the ongoing saga of whether Congress and the president will avert a government ...
Study finds contradictory role of RIP1 protein in the liver during sepsisResearchers from Rhode Island Hospital have identified a protein that plays a dual role in the liver...
ZIOPHARM's darinaparsin receives EMA COMP orphan drug designation for treatment of peripheral T-cell lymphomaZIOPHARM Oncology, Inc., announced today that The Committee for Orphan Medicinal Products (COMP) wit...
BIDMC scientist wins 2011 Pezcoller Foundation-AACR International Award for cancer researchBeth Israel Deaconess Medical Center cancer geneticist Pier Paolo Pandolfi, MD, PhD, is the recipien...
Xeloda may reduce recurrence of faster growing breast cancers: StudyJoyce O'Shaughnessy, M.D., medical director and co-chair of the Breast Cancer Research Committee, US...
Beta-carotene from food sources is insufficient in substantial part of populationThe intake of preformed vitamin A from animal products is not sufficient in parts of the population ...
OncoGenex reports net income in second-quarter 2010 against loss last yearOncoGenex Pharmaceuticals, Inc. today reported unaudited financial results for the three and six mon...
Cancer cells utilize fructose as an alternative to glucose for fueling growth: StudyA study published in the August issue of Cancer Research has resulted in several premature and poten...
Celsion reports net loss of $2.6M for second-quarter 2010Celsion Corporation, a biotechnology drug development company, today announced financial results for...
AVEO second-quarter total revenues increase to $15.6 millionAVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and comme...
SBUMC uses RapidArc radiotherapy technology to treat cancer patientsA breakthrough external beam radiotherapy technology that is fast, precise, and has optimal dose del...
Takeda enters co-promotion agreement with Janssen Pharma for VELCADETakeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncolog...
Majority of Americans fall short in consuming key phytonutrientsAmericans who fall short in meeting their daily fruit and vegetable intakes based on government guid...
Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 millionAbraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financi...
EMBL scientists identify genes involved in human cell divisionName a human gene, and you'll find a movie online showing you what happens to cells when it is switc...
Connecticut policy makers providing cost effective dental care to children, says reportConnecticut is a national leader in addressing the dental health needs of its children, according to...
Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disordersThe new decade may herald an era of cell therapy -- treating human diseases by delivering highly spe...
Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancerNovelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics t...
FDA evaluates Phase III randomized trial in acute myeloid leukemiaVION PHARMACEUTICALS, INC., announced today that the U.S. Food and Drug Administration ("FDA") had r...
Elusys Therapeutics receives contract to speed up drug development for AnthraxThe HHS Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to E...
Pharmadeal Financials database offers information on therapeutic license dealsResearch and Markets (http://www.researchandmarkets.com/research/5577e0/pharmadeal_financi) has anno...
Stem cell treatment: A new hope for Multiple SclerosisRNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell...
Call for every health insurance plan to cover PhenylketonuriaCredit Senators John Kerry (D-MA) and Robert Casey (D-PA) with a significant contribution to the hea...
HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancerPrevious studies have indicated that the heparanase (HPA) is correlated with histopathological param...
BrainStorm Cell's therapeutic approach has potential for treatment of neurodegenerative diseasesBrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeut...
Pfizer and Flamel Technologies sign license agreementFlamel Technologies today announced that Pfizer (NYSE:PFE) has exercised its option to license Flame...
FDA approves new oral medication for renal cell carcinomaThe U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be appr...
First-quarter fiscal 2010 results announced by Peregrine PharmaceuticalsPeregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quart...
New market research report examines AMD and diabetic retinopathy pharmaceutical marketReportlinker.com announces that a new market research report is available in its catalogue.
Immune responses to flu vaccine are diminished in lupus patientsPatients with the autoimmune disease systemic lupus erythematosus (SLE) have an increased risk of in...
Vegetarians less likely to develop cancer than meat eatersVegetarians are 12 per cent less likely to develop cancer than meat eaters, according to new researc...
Discovery of new gene associated with Lou Gehrig's diseaseA collaborative research effort spanning nearly a decade between researchers at Massachusetts Genera...
New 'Track Your Drinking' Google gadgetIf you find it difficult to keep track of just how many glasses of wine you've consumed during the w...
Whole-organ genomic survey depicts journey from normal to malignant cellWhole-organ maps that superimpose genetic information over the terrain of cancerous bladders chart t...
Mothers less likely to pursue HPV vaccination for youngest daughtersBecause the first national study of its kind has found that U.S. mothers report they are less likely...
Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumorsResearchers in a multi-institutional study led by Cincinnati Children's Hospital Medical Center slow...
Positive results for novel anti-cancer drug ECO-4601Researchers report positive results from a Phase I/II clinical trial of a novel anti-cancer drug whi...
Anti-anemia drug darbepoetin alfa no better than placebo for cancer patientsResults from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease...
FDA approval for Gemzar for ovarian cancerEli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approv...
IVF gives women false expectationsExperts are warning that women are risking their chances of having children because they are delayin...
Researchers set a new standard in the design and engineering of nuclear hormone receptor-based genetic on-off switchesResearchers at the University of Illinois at Urbana-Champaign have set a new standard in the design ...
Study links meat consumption to colon cancerA major American Cancer Society study finds people who reported the highest consumption of red and p...
Whooping cough at epidemic levels in New ZealandThe Ministry of Health's Dr Alison Roberts says "Numbers have been on the rise since June this year,...
Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetesResearch presented today showed that the investigational drug, LAF237, the first in a new class, imp...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.